Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal testosterone patch in menopausal women with low libido
2004-001222-25Phase 3Completed
- Sponsor
- Procter & Gamble
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of testosterone in hypoactive sexual desire disorder (HSDD) (3 arms), sponsored by Procter & Gamble. Primary endpoint: Change from baseline in 4-week frequency of total satisfying episodes at week 24. Started Jul 2004; status: completed.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on 2004-001222-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001222-25.